Loading
A phase 3 trial of tislelizumab and pembrolizumab in lung cancer, run by AIO-Studien-gGmbH, not yet recruiting.
Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden is a phase 3, randomised interventional study registered as NCT07715396 by AIO-Studien-gGmbH, with a registry enrolment figure of 230 participants, started 2026-10-30 and due to reach its primary completion in 2031-10-30. Interventions recorded: Tislelizumab; Tislelizumab Combined With Chemotherapy; Pembrolizumab. Conditions listed: Non-small Cell Lung Cancer Metastatic. Primary outcome: Progression-free survival. Lung eligibility wording from the registry: "Histologically confirmed and treatment-naïve non-small cell lung cancer UICC 9th stage IV". Sites: Germany. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Pembrolizumab, Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Pembrolizumab, Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Pembrolizumab, Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares BeOne Medicines (formerly BeiGene), Tislelizumab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Pembrolizumab, Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.